Said Saim
Chief Tech/Sci/R&D Officer bij EYEPOINT PHARMACEUTICALS, INC.
Profiel
Said Saim is currently working as the Chief Technology Officer & Senior VP at EyePoint Pharmaceuticals, Inc. Prior to his current position, he worked as the Senior Director-Pharmaceutical Development at Collegium Pharmaceutical, Inc. from 2008 to 2013.
He also held the position of Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and Assistant Research Professor at Higuchi Bioscience Center.
Dr. Saim completed his graduate and doctorate degrees at the University of Kansas.
Actieve functies van Said Saim
Bedrijven | Functie | Begin |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10-06-2019 |
Eerdere bekende functies van Said Saim
Bedrijven | Functie | Einde |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Opleiding van Said Saim
University of Kansas | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Higuchi Bioscience Center |